Package 65862-301-05

{"route": ["ORAL"], "spl_id": "b4553ee9-214c-43d5-b704-16f4eee5f2b6", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["G70B4ETF4S"], "rxcui": ["403875"], "spl_set_id": ["cdfb7868-3eba-46e1-a286-ca40760fd98d"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (65862-301-05)", "package_ndc": "65862-301-05", "marketing_start_date": "20230315"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (65862-301-30)", "package_ndc": "65862-301-30", "marketing_start_date": "20230315"}], "brand_name": "Emtricitabine", "product_id": "65862-301_b4553ee9-214c-43d5-b704-16f4eee5f2b6", "dosage_form": "CAPSULE", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "65862-301", "generic_name": "Emtricitabine", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}], "application_number": "ANDA079188", "marketing_category": "ANDA", "marketing_start_date": "20230315", "listing_expiration_date": "20261231"}